Hal Cohen | Jun 9, 2002 | 5 min read
For many laboratories, monkey business is no laughing matter. The rise in bioterrorism research after the Sept. 11 tragedy puts an increased demand on the already limited supply of rhesus monkeys for research ("Monkey deficit crimps laboratories as scientists scramble for alternatives," The Wall Street Journal, May 14, 2002). The genetic similarity between humans and rhesus monkeys has helped establish the species as the preferred nonhuman primate model for medical research, making the monkeys e